These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23940095)

  • 1. Distal ulnar changes in children with thalassemia and deferiprone related arthropathy.
    Sharma R; Anand R; Chandra J; Seth A; Pemde H; Singh V
    Pediatr Blood Cancer; 2013 Dec; 60(12):1957-62. PubMed ID: 23940095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wrist Joint Skeletal Changes in Children With Transfusion-dependent Thalassemia.
    Dhawan P; Kanojia RK; Chandra J; Kumar A; Anand R; Gupta S
    J Pediatr Orthop; 2020 Jul; 40(6):e473-e478. PubMed ID: 32501918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic and MRI features of deferiprone-related arthropathy of the knees in patients with beta-thalassemia.
    Kellenberger CJ; Schmugge M; Saurenmann T; Di Gennaro L; Eber SW; Willi UV; Babyn PS
    AJR Am J Roentgenol; 2004 Oct; 183(4):989-94. PubMed ID: 15385291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia.
    Botzenhardt S; Sing CW; Wong IC; Chan GC; Wong LY; Felisi M; Rascher W; Ceci A; Neubert A
    Curr Drug Saf; 2016; 11(2):137-44. PubMed ID: 26419768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of deferiprone for iron chelation in patients with transfusion-dependent thalassaemia.
    Jamuar SS; Lai AH; Tan AM; Chan MY; Tan ES; Ng IS
    J Paediatr Child Health; 2011 Nov; 47(11):812-7. PubMed ID: 21902752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arthropathy in thalassaemia patients receiving deferiprone.
    al-Refaie FN; Wonke B; Hoffbrand AV
    Lancet; 1994 Jul; 344(8917):262-3. PubMed ID: 7913175
    [No Abstract]   [Full Text] [Related]  

  • 7. Wrist Deformity in Children and Adolescents with b-thalassemia on Oral Iron Chelation Therapy.
    Merchant RH; Kulkarni A; Doctor PN; Choudhari A; Patkar DP
    Indian Pediatr; 2019 Jan; 56(1):41-44. PubMed ID: 30806360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature.
    Vlachaki E; Tselios K; Perifanis V; Tsatra I; Tsayas I
    Clin Rheumatol; 2008 Nov; 27(11):1459-61. PubMed ID: 18663554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of oral iron chelator deferiprone in young thalassaemics.
    Naithani R; Chandra J; Sharma S
    Eur J Haematol; 2005 Mar; 74(3):217-20. PubMed ID: 15693791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A; Manz C; Naja M; Eltagui M; Tarabishi C; Youssry I; Sobh H; Hamdy M; Sharaf I; Mostafa A; Shaker O; Hoffbrand AV; Taher A
    Ann Hematol; 2008 Jul; 87(7):545-50. PubMed ID: 18351337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.
    Parakh N; Sharma R; Prakash O; Mahto D; Dhingra B; Sharma S; Chandra J
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e433-4. PubMed ID: 26165407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload.
    ElAlfy MS; Sari TT; Lee CL; Tricta F; El-Beshlawy A
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):601-5. PubMed ID: 20921906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of deferiprone and deferrioxamine for the treatment of transfusional iron overload in children with beta thalassemia major.
    Waheed N; Ali S; Butt MA
    J Ayub Med Coll Abbottabad; 2014; 26(3):297-300. PubMed ID: 25671931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthropathy in thalassaemia patients receiving deferiprone.
    Berkovitch M; Laxer RM; Inman R; Koren G; Pritzker KP; Fritzler MJ; Olivieri NF
    Lancet; 1994 Jun; 343(8911):1471-2. PubMed ID: 7911181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.
    Olivieri NF; Brittenham GM; McLaren CE; Templeton DM; Cameron RG; McClelland RA; Burt AD; Fleming KA
    N Engl J Med; 1998 Aug; 339(7):417-23. PubMed ID: 9700174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Ser and Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients.
    Dadheech S; Rao AV; Shaheen U; Hussien MD; Jain S; Jyothy A; Munshi A
    Gene; 2013 Dec; 531(2):301-5. PubMed ID: 24036429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of oral iron chelator L1.
    Kontoghiorghes GJ; Nasseri-Sina P; Goddard JG; Barr JM; Nortey P; Sheppard LN
    Lancet; 1989 Aug; 2(8660):457-8. PubMed ID: 2569645
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).
    Rombos Y; Tzanetea R; Konstantopoulos K; Simitzis S; Zervas C; Kyriaki P; Kavouklis M; Aessopos A; Sakellaropoulos N; Karagiorga M; Kalotychou V; Loukopoulos D
    Haematologica; 2000 Feb; 85(2):115-7. PubMed ID: 10681716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.